Prioritizing environmental chemicals for obesity and diabetes outcomes research: A screening approach using ToxCast™ high-throughput data

Environmental Health Perspectives

Volumn 124, Issue 8, 2016, Pages 1141-1154

  Auerbach, Scott ^a   Filer, Dayne ^b   Reif, David ^c   Walker, Vickie ^a   Holloway, Alison C ^d   Schlezinger, Jennifer ^e   Srinivasan, Supriya ^f   Svoboda, Daniel ^g   Judson, Richard ^b   Bucher, John R ^a   Thayer, Kristina A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

^g National Institute of Environmental Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADENOSINE 2' PHOSPHATE; ADIPOPHILIN; AMITRAZ; CHLORPROMAZINE; DEXAMETHASONE SODIUM PHOSPHATE; ENVIRONMENTAL CHEMICAL; GLUCOCORTICOID RECEPTOR; HALOPERIDOL; NICOTINE; ORGANOPHOSPHATE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SULFONYLUREA; TOLAZAMIDE; TROGLITAZONE; POLLUTANT;

BIODIVERSITY; CALCULATION; CELL FUNCTION; CLUSTER ANALYSIS; CONCEPTUAL FRAMEWORK; CYTOTOXICITY; DIABETES MELLITUS; ENVIRONMENTAL CHANGE; FEEDING BEHAVIOR; GENOTYPE PHENOTYPE CORRELATION; GOVERNMENT; HIGH THROUGHPUT SCREENING; HUMAN; HYPERGLYCEMIA; HYPOLIPEMIA; INSULIN SENSITIVITY; KNOWLEDGE; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PANCREAS ISLET; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RESEARCH; REVIEW; SCORING SYSTEM; CHEMICALLY INDUCED; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; FACTUAL DATABASE; POLLUTANT; RISK ASSESSMENT; STANDARDS; STATISTICS AND NUMERICAL DATA; TOXICITY; UNITED STATES;

DATABASES, FACTUAL; DIABETES MELLITUS; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 84980316460     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1510456     Document Type: Review

References (97)

1. Abu-Basha EA, Yibchok-Anun S, Hopper DL, Hsu WH. 1999. Effects of the pesticide amitraz and its metab-olite BTS 27271 on insulin and glucagon secretion from the perfused rat pancreas: involvement of α2D-adrenergic receptors. Metab 48(11):1461-1469.
2. Amireault P, Sibon D, Côté F. 2013. Life without periph-eral serotonin: insights from tryptophan hydroxy-lase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. ACS Chem Neurosci 4(1):64-71.
3. Barros RP, Gustafsson JA. 2011. Estrogen recep-tors and the metabolic network. Cell Metab 14(3):289-299.
4. Behl M, Rao D, Aagaard K, Davidson TL, Levin ED, Slotkin TA, et al. 2013. Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a National Toxicology Program workshop review. Environ Health Perspect 121:170-180, doi: 10.1289/ehp.1205404.
5. Bonet ML, Ribot J, Palou A. 2012. Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim Biophys Acta 1821(1):177-189.
6. Bonnelye E, Aubin JE. 2013. An energetic orphan in an endocrine tissue: a revised perspective of the function of estrogen receptor-related receptor alpha in bone and cartilage. J Bone Miner Res 28(2):225-233.
7. Bonsall JL, Turnbull GJ. 1983. Extrapolation from safety data to management of poisoning with reference to amitraz (a formamidine pesticide) and xylene. Hum Toxicol 2(4):587-592.
8. Caicedo A. 2013. Paracrine and autocrine inter actions in the human islet: more than meets the eye. Semin Cell Dev Biol 24(1):11-21.
9. CalEPA (California Environmental Protection Agency). 1995. Amitraz Risk Characterization Document. Volume 1. Sacramento, CA:California Environmental Protection Agency Health Assessment Section, Medical Toxicology Branch, Department of Pesticide Regulation. Available: http://www.cdpr.ca.gov/docs/risk/rcd/amitraz.pdf [accessed 25 September 2015].
10. Cascino P, Nectoux M, Guiraud G, Bounias M. 1989. The formamidine amitraz as a hyperglycemic alpha-agonist in worker honeybees (Apis mellifera mellifera L.) in vivo. Biomed Environ Sci 2(2):106-114.
11. CDC (Centers for Disease Control and Prevention). 2011. National Diabetes Fact Sheet, 2011. Available: http://www.cdc.gov/diabetes/pubs/pdf/ methods11.pdf [accessed 12 December 2011].
12. CDC. 2013. Fourth Report on Human Exposure to Environmental Chemicals (Updated Tables, September 2012). Atlanta, GA:U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available: http://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Sep2013.pdf [accessed 25 May 2014].
13. Chamorro-García R, Sahu M, Abbey RJ, Laude J, Pham N, Blumberg B. 2013. Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ Health Perspect 121:359-366, doi: 10.1289/ehp.1205701.
14. Chen TH, Hsu WH. 1994. Inhibition of insulin release by a formamidine pesticide amitraz and its metabo-lites in a rat beta-cell line: an action mediated by alpha-2 adrenoceptors, a GTP-binding protein and a decrease in cyclic AMP. J Pharmacol Exp Ther 271(3):1240-1245.
15. Dahlquist GG, Nyström L, Patterson CC, Swedish Childhood Diabetes Study Group, Diabetes Incidence in Sweden Study Group. 2011. Incidence of type 1 diabetes in Sweden among individuals aged 0-34 years, 1983-2007: an analysis of time trends. Diabetes Care 34(8):1754-1759.
16. Dang DK, Haines S, Ponte CD, Calis KA. 2005. Glucose and insulin dysregulation. In: Drug-Induced Diseases: Prevention, Detection, and Management (Tisdale JE, Miller DA, eds) Bethesda, MD:American Society of Health-System Pharmacist, Inc., 365-378.
17. Davis AP, Murphy CG, Johnson R, Lay JM, Lennon-Hopkins K, Saraceni-Richards C, et al. 2013. The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Res 41(database issue):D1104-D1114.
18. de Bono M, Bargmann CI. 1998. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C. elegans. Cell 94(5):679-689.
19. Deblois G, Giguère V. 2011. Functional and physi-ological genomics of estrogen-related receptors (ERRs) in health and disease. Biochim Biophys Acta 1812(8):1032-1040.
20. DIAMOND Project Group. 2006. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 23(8):857-866.
21. Eldor R, DeFronzo RA, Abdul-Ghani M. 2013. In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion. Diabetes Care 36(suppl 2):S162-S174.
22. Esposti MD, Ngo A, Myers MA. 1996. Inhibition of mitochondrial complex I may account for IDDM induced by intoxication with the rodenticide Vacor. Diabetes 45(11):1531-1534.
23. Farmer SR. 2006. Transcriptional control of adipocyte formation. Cell Metab 4(4):263-273.
24. Filer D, Patisaul HB, Schug T, Reif D, Thayer K. 2014. Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. Curr Opin Pharmacol 19:145-152.
25. Fletcher JS, Pfleeger TG, Ratsch HC. 1994. Potential environmental risks associated with the new sulfonylurea herbicides. Environ Sci Technol 28(6):1204, doi: 10.1021/es00055a602.
26. Frey SK, Vogel S. 2011. Vitamin A metabolism and adipose tissue biology. Nutrients 3(1):27-39.
27. Frijters R, Heupers B, van Beek P, Bouwhuis M, van Schaik R, de Vlieg J, et al. 2008. CoPub: a literature-based keyword enrichment tool for microarray data analysis. Nucleic Acids Res 36(Web server issue):W406-W410.
28. Gallanosa AG, Spyker DA, Curnow RT. 1981. Diabetes mellitus associated with autonomic and peripheral neuropathy after Vacor rodenticide poisoning: a review. Clin Toxicol 18(4):441-449.
29. Gille A, Bodor ET, Ahmed K, Offermanns S. 2008. Nicotinic acid: pharmacological effects and mechanisms of action. Annu Rev Pharmacol Toxicol 48:79-106.
30. Gong J, Liu X, Cao X, Diao Y, Gao D, Li H, et al. 2013. PTID: an integrated web resource and computational tool for agrochemical discovery. Bioinformatics 29(2):292-294.
31. Greeley SA, Naylor RN, Philipson LH, Bell GI. 2011. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep 11(6):519-532.
32. Grün F, Blumberg B. 2006. Environmental obeso-gens: organotins and endocrine disruption via nuclear receptor signalling. Endocrinology 147(6 suppl):S50-S55.
33. Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, et al. 2006. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20(9):2141-2155.
34. Gupta D, Kono T, Evans-Molina C. 2010. The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus. Diabetes Obes Metab 12(12):1036-1047.
35. Hernandez C, Molusky M, Li Y, Li S, Lin JD. 2010. Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid. Cell Metab 12(4):411-419.
36. Hsu WH, Schaffer DD. 1988. Effects of topical appli-cation of amitraz on plasma glucose and insulin concentrations in dogs. Am J Vet Res 49(1):130-131.
37. Hugnet C, Buronrosse F, Pineau X, Cadoré JL, Lorgue G, Berny PJ. 1996. Toxicity and kinetics of amitraz in dogs. Am J Vet Res 57(10):1506-1510.
38. Hummasti S, Laffitte BA, Watson MA, Galardi C, Chao LC, Ramamurthy L, et al. 2004. Liver X recep-tors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. J Lipid Res 45(4):616-625.
39. Ino T. 2010. Maternal smoking during pregnancy and offspring obesity: meta-analysis. Pediatr Int 52(1):94-99.
40. Janesick A, Blumberg B. 2011. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today 93(1):34-50.
41. Ju D, He J, Zhao L, Zheng X, Yang G. 2012. Estrogen related receptor α-induced adipogenesis is PGC-1β-dependent. Mol Biol Rep 39(3):3343-3354.
42. Judson RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Mortensen HM, et al. 2010. In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ Health Perspect 118:485-492, doi: 10.1289/ehp.0901392.
43. Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. 2014. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42(database issue):D199-D205.
44. Karam JH, Lewitt PA, Young CW, Nowlain RE, Frankel BJ, Fujiya H, et al. 1980. Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 29(12):971-978.
45. Karges B, Meissner T, Icks A, Kapellen T, Holl RW. 2011. Management of diabetes mellitus in infants. Nat Rev Endocrinol 8(4):201-211.
46. Kavlock R, Chandler K, Houck K, Hunter S, Judson R, Kleinstreuer N, et al. 2012. Update on EPA’s ToxCast program: providing high throughput decision support tools for chemical risk manage-ment. Chem Res Toxicol 25(7):1287-1302.
47. Kirchner S, Kieu T, Chow C, Casey S, Blumberg B. 2010. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol 24(3):526-539.
48. Kuo CC, Moon K, Thayer KA, Navas-Acien A. 2013. Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep 13(6):831-849.
49. Lee TH, Doi K, Yoshida M, Baba S. 1988. Morphological study of nervous system in Vacor-induced diabetic rats. Diabetes Res Clin Pract 4(4):275-279.
50. Mandrika I, Petrovska R, Klovins J. 2010. Evidence for constitutive dimerization of niacin receptor subtypes. Biochem Biophys Res Commun 395(2):281-287.
51. Matsui H, Wada O, Manabe S, Ushijima Y, Fujikura T. 1984. Species difference in sensitivity to the diabeto-genic action of triphenyltin hydroxide. Experientia 40(4):377-378.
52. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, et al. 2012. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 120:1658-1670, doi: 10.1289/ ehp.1104579.
53. Miller LV, Stokes JD, Silpipat C. 1978. Diabetes mellitus and autonomic dysfunction after vacor rodenticide ingestion. Diabetes Care 1(2):73-76.
54. Mindel JS. 1986. N-3-pyridylmethyl-N´-p-nitrophenylurea ocular toxicity in man and an animal model. Trans Am Ophthalmol Soc 84:389-428.
55. Miura Y, Hori Y, Kimura S, Hachiya H, Sakurai Y, Inoue K, et al. 2012. Triphenyltin impairs insulin secretion by decreasing glucose-induced NADP(H) and ATP production in hamster pancreatic β-cells. Toxicology 299(2-3):165-171.
56. 2+ response to glucose and gastric inhibitory polypeptide in pancreatic β-cells from triphenyltin-induced diabetic hamster. Endocrinology 138(7):2769-2775.
57. 2+ response to glucose and acetylcholine in pancreatic β-cells from hamster. Toxicol Appl Pharmacol 174(1):1-9.
58. 2+ associated with insulin secre-tion in hamster pancreatic β-cells. Toxicol Appl Pharmacol 216(3):363-372.
59. Mukherjee R, Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, et al. 1997. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 386(6623):407-410.
60. Musil R, Obermeier M, Russ P, Hamerle M. 2015. Weight gain and antipsychotics: a drug safety review. Expert Opin Drug Saf 14(1):73-96.
61. NLM (National Library of Medicine). 2014. Genetics Home Reference. KCNJ11: potassium voltage-gated channel subfamily J member 11. Bethesda, MD:NLM. Available: http://ghr.nlm.nih.gov/gene/KCNJ11 [accessed 15 February 2014].
62. Noble T, Stieglitz J, Srinivasan S. 2013. An integrated serotonin and octopamine neuronal circuit directs the release of an endocrine signal to control C. elegans body fat. Cell Metab 18(5):672-684.
63. Ogden C, Carroll M. 2010. Prevalence of Obesity Among Children and Adolescents: United States, Trends 1963-1965 Through 2007-2008. Atlanta, GA:Centers for Diesease Control and Prevention-National Center for Health Statistics, Health E-Stat. Available: http://www.cdc.gov/nchs/data/hestat/obesity_child_07_08/obesity_child_07_08.pdf [accessed 12 December 2011].
64. Ogino K, Inukai T, Miura Y, Matsui H, Takemura Y. 1996. Triphenyltin chloride induces glucose intol-erance by the suppression of insulin release from hamster pancreatic β-cells. Exp Clin Endocrinol Diabetes 104(5):409-411.
65. Ohhira S, Matsui H, Watanabe K. 1999. Effects of pretreatment with cytochrome P-450 inducers, especially phenobarbital on triphenyltin metabolism and toxicity in hamsters. Toxicology 137(3):151-159.
66. Oken E, Levitan EB, Gillman MW. 2008. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond) 32(2):201-210.
67. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. 2009. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373(9680):2027-2033.
68. Peters KS, Tong TG, Kutz K, Benowitz NL. 1981. Diabetes mellitus and orthostatic hypotension resulting from ingestion of Vacor rat poison: endo-crine and autonomic function studies. West J Med 134(1):65-68.
69. Pont A, Rubino JM, Bishop D, Peal R. 1979. Diabetes mellitus and neuropathy following Vacor ingestion in man. Arch Intern Med 139(2):185-187.
70. Prosser PR, Karam JH. 1978. Diabetes mellitus following rodenticide ingestion in man. JAMA 239(12):1148-1150.
71. R Core Team. 2014. R: A Language and Environment for Statistical Computing. Vienna, Austria:R Foundation for Statistical Computing. Available: http://www.R-project.org/ [accessed 12 May 2015].
72. Ranhotra HS. 2010. The estrogen-related receptor alpha: the oldest, yet an energetic orphan with robust biological functions. J Recept Signal Transduct Res 30(4):193-205.
73. Reif DM, Sypa M, Lock EF, Wright FA, Wilson A, Cathey T, et al. 2013. ToxPi GUI: an interactive visualization tool for transparent integration of data from diverse sources of evidence. Bioinformatics 29(3):402-403.
74. Remedi MS, Nichols CG. 2008. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic β-cells. PLoS Med 5(10):e206, doi: 10.1371/journal.pmed.0050206.
75. Sawin ER, Ranganathan R, Horvitz HR. 2000. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experi-ence through a serotonergic pathway. Neuron 26(3):619-631.
76. Sheehan A. 2005. Weight gain. In: Drug-Induced Diseases: Prevention, Detection, and Management (Tisdale JE, Miller DA, eds). Bethesda, MD:American Society of Health-System Pharmacist, Inc., 409-420.
77. Skibicka KP, Dickson SL. 2013. Enteroendocrine hormones—central effects on behavior. Curr Opin Pharmacol 13(6):977-982.
78. Smith BE, Hsu WH, Yang PC. 1990. Amitraz-induced glucose intolerance in rats: antagonism by yohim-bine but not by prazosin. Arch Toxicol 64(8):680-683.
79. Srinivasan S. 2015. Regulation of body fat in Caenorhabditis elegans. Annu Rev Physiol 77:161-178.
80. Srinivasan S, Sadegh L, Elle IC, Christensen AG, Faergeman NJ, Ashrafi K. 2008. Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms. Cell Metab 7(6):533-544.
81. Taniguchi H, Yamashiro Y, Chung MY, Hara Y, Ishihara K, Ejiri K, et al. 1989. Vacor inhibits insulin release from islets in vitro. J Endocrinol Invest 12(4):273-275.
82. Taylor DM, McAskill RC. 2000. Atypical antipsychotics and weight gain—a systematic review. Acta Psychiatr Scand 101(6):416-432.
83. Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, Devito M, et al. 2013. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a National Toxicology Program workshop review. Environ Health Perspect 121:774-783, doi: 10.1289/ ehp.1205502.
84. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. 2012. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop report. Environ Health Perspect 120:779-789, doi: 10.1289/ehp.1104597.
85. Thévenod F. 2002. Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins. Am J Physiol Cell Physiol 283(3):C651-C672.
86. Tiano JP, Mauvais-Jarvis F. 2012. Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat Rev Endocrinol 8(6):342-351.
87. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. 1994. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8(10):1224-1234.
88. Ustione A, Piston DW, Harris PE. 2013. Minireview: dopa-minergic regulation of insulin secretion from the pancreatic islet. Mol Endocrinol 27(8):1198-1207.
89. Villena JA, Kralli A. 2008. ERRα: a metabolic function for the oldest orphan. Trends Endocrinol Metab 19(8):269-276.
90. Wang YX. 2010. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 20(2):124-137.
91. Watanabe M, Watanabe K, Matsui H. 2002. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits. Vet Hum Toxicol 44(3):140-144.
92. Wilson GL, Gaines KL. 1983. Effects of the rodenti-cide Vacor on cultured rat pancreatic beta cells. Toxicol Appl Pharmacol 68(3):375-379.
93. Yang M, Bhowmik D, Wang X, Abughosh S. 2013. Does combination pharmacological interven-tion for smoking cessation prevent post-cessation weight gain? A systemic review. Addict Behav 38(3):1865-1875.
94. Yoon JW. 1990. The role of viruses and environmental factors in the induction of diabetes. Curr Top Microbiol Immunol 164:95-123.
95. Zhang C, Bao W, Rong Y, Yang H, Bowers K, Yeung E, et al. 2013. Genetic variants and the risk of gesta-tional diabetes mellitus: a systematic review. Hum Reprod Update 19(4):376-390.
96. Zoli M, Picciotto MR. 2012. Nicotinic regulation of energy homeostasis. Nicotine Tob Res 14(11):1270-1290.
97. Zuo Z, Chen S, Wu T, Zhang J, Su Y, Chen Y, et al. 2011. Tributyltin causes obesity and hepatic steatosis in male mice. Environ Toxicol 26(1):79-85.